Solventum (NYSE:SOLV) today announced that it commenced offers to purchase outstanding notes for up to $1.75 billion.

Restor3d announced today that it entered into a strategic investment partnership with global private market firm Partners ...

Boston Scientific (NYSE: BSX) announced today that it initiated a new trial to assess its Agent DCB compared to the standard ...

Zeiss Medical Technology announced today that it received CE mark approval for its Cirrus PathFinder clinical support tool.

Method AI announced today that it raised $20 million in Series A funding to support its novel surgical ultrasound platform. The Boston-based company, co-founded by former Corindus COO Doug Teany, who ...